GAVI

Micron Biomedical Appoints Global Health Pioneer and Champion of Vaccine Access, Dr. Seth Berkley, as Scientific Advisor to the CEO

Retrieved on: 
Tuesday, February 27, 2024
Medicine, Vaccine, Weapon, Disease, Micrometre, GAVI, Global health, Pharmaceutical industry

ATLANTA, Feb. 27, 2024 /PRNewswire/ -- Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that simplify and improve the transport, storage, and administration of drugs and vaccines, today announced the appointment of global public health pioneer, Dr. Seth Berkley, as scientific advisor to the CEO. In this capacity, Dr. Berkley will guide the company's strategic manufacturing and supply chain efforts, as well as the go-to-market strategy including quality, distribution and pricing. 

Key Points: 
  • In this capacity, Dr. Berkley will guide the company's strategic manufacturing and supply chain efforts, as well as the go-to-market strategy including quality, distribution and pricing.
  • "It's time our current way of delivering injectable pharmaceuticals was disrupted," said Dr. Seth Berkley.
  • "As I continue my work championing equitable access to vaccines and improving the way the world prevents and responds to disease, I am thrilled to take an active role in improving global health as a strategic technical advisor to Micron Biomedical."
  • Last year, Micron Biomedical announced it is working to build one of the first mass manufacturing facilities of needle free vaccines in the world.

Particles for Humanity Establishes Global Advisory Board in Fight Against Vitamin A Deficiency

Retrieved on: 
Tuesday, January 23, 2024
Research, Corporation, University, GAIN, Entrepreneurship, MFR, Mulago Foundation, Poverty, United, Nutrition (journal), Assistant, Learning, Vitamin A, Humanity, Country, Corporate governance, GAVI, Partner, Cadbury Nigeria Plc, Organization, Food fortification, Education, Vitamin A deficiency, UNICEF, Head, Nutrition International (organization), Parthian Partners Limited, Finance, Federal republic, Multimedia, Global health, Bill, Advisory, ACA, Malnutrition, Pregnancy, Advisory board, United Nations, Government, Global Alliance, Management

The four-person advisory board brings significant experience in the fields of malnutrition, food fortification, global health, entrepreneurship, and African markets, which will strengthen the company's strategic plans.

Key Points: 
  • The four-person advisory board brings significant experience in the fields of malnutrition, food fortification, global health, entrepreneurship, and African markets, which will strengthen the company's strategic plans.
  • Members of the Advisory Board bring a diverse skill set from long careers working throughout Africa, Asia, and more.
  • Advisory Board members include:
    Kul Chandra Gautam is the former Deputy Executive Director of UNICEF and Assistant Secretary-General of the United Nations.
  • "It is a privilege to welcome these brilliant individuals onto the Particles for Humanity Advisory Board.

Katalin Karikó and Anne Schuchat Receive 2023 Fries Prize for Improving Health

Retrieved on: 
Sunday, November 12, 2023
DRS, Infant, Pneumonia, Nobel Prize, Cell, Epidemic Intelligence Service, GAVI, Immunization, CDC, Group B streptococcal infection, NCIRD, Doctor of Philosophy, USPHS, University of Szeged, COVID, Organization, Erich Fried Prize, Health, American Public Health Association, RADM, Parent, ARD International Music Competition, Letter, Public, Meningitis, RNA, Therapy, University of Pennsylvania, Anne Schuchat, Infection, APHA, University, RET, SARS, Research, Developmental Biology (journal), Death, Vaccine, Messenger, COVID-19, GBS, Nursing, Management, Pharmaceutical industry, Physiology, Ophthalmology, Medicine, MD

ATLANTA, Nov. 12, 2023 /PRNewswire/ -- Nobel Prize Winner Katalin Karikó, PhD, and former Centers for Disease Control and Prevention (CDC) Principal Deputy Director Anne Schuchat, MD (RADM, USPHS, RET), today received the 2023 Fries Prize for Improving Health.

Key Points: 
  • ATLANTA, Nov. 12, 2023 /PRNewswire/ -- Nobel Prize Winner Katalin Karikó, PhD, and former Centers for Disease Control and Prevention (CDC) Principal Deputy Director Anne Schuchat, MD (RADM, USPHS, RET), today received the 2023 Fries Prize for Improving Health.
  • The Fries Prize for Improving Health award was presented this morning at the American Public Health Association's (APHA) annual meeting, which is taking place in Atlanta.
  • The monetary award for the Fries Prize for Improving Health is $70,000, which will be divided between the recipients.
  • As of 2016, the CDC Foundation manages and administers the Fries Foundation's public health award programs, which include the Fries Prize for Improving Health and the Elizabeth Fries Health Education Award.

Gavi, the Vaccine Alliance, and the Eleanor Crook Foundation Announce $2 Million Investment in an Integrated Child Survival Project

Retrieved on: 
Wednesday, June 14, 2023
Vaccine, Partnership, Private, Vaccination, Malnutrition, Research, Death, US, GAVI, Sovereign, Risk, ECF, Child, Gavi, Mortality, Immunization, Conference, Caregiver, Dietary supplement

MADRID, June 14, 2023 /PRNewswire/ -- Gavi, the Vaccine Alliance, and the Eleanor Crook Foundation (ECF) announced at the Global Vaccine Impact Conference a US$2 million joint investment in the NutriVax Project, an integrated nutrition and immunization research partnership. Each organization will contribute US$1 million to this innovative project, which will integrate life-saving interventions that traditionally have been separate – delivery of immunizations and malnutrition prevention products. Research funded by this investment has the potential to be ground-breaking for continuous improvement in countries hit by the double burden of malnutrition and low vaccination coverage.

Key Points: 
  • MADRID, June 14, 2023 /PRNewswire/ -- Gavi, the Vaccine Alliance, and the Eleanor Crook Foundation (ECF) announced at the Global Vaccine Impact Conference a US$2 million joint investment in the NutriVax Project, an integrated nutrition and immunization research partnership.
  • Each organization will contribute US$1 million to this innovative project, which will integrate life-saving interventions that traditionally have been separate – delivery of immunizations and malnutrition prevention products.
  • Research funded by this investment has the potential to be ground-breaking for continuous improvement in countries hit by the double burden of malnutrition and low vaccination coverage.
  • The Eleanor Crook Foundation is excited to join forces with the Gavi Alliance to test this innovative bundle at scale."

SK bioscience Presents Solution for Equitable Access of Vaccine at Regionalized Vaccine Manufacturing Collaborative of World Economic Forum

Retrieved on: 
Tuesday, May 23, 2023
Epidemic, Coalition for Epidemic Preparedness Innovations, Pan American Health Organization, SK, Multilateralism, WEF, Glocalization, Coalition, PAHO, CEPI, World Health Assembly, COVID-19, GAVI, African Center for Economic Transformation, Messenger, RVMC, Rochester Regional Health, Gavi, WHO, Vaccine, Ahn, World Health Organization, Pharmaceutical industry, Security (finance), Immunization, Health

Jaeyong Ahn, CEO of SK bioscience, presents the 'Glocalization' project to secure the global vaccine accessibility, claiming the importance of international cooperation to establish a regional-based vaccine hub at the Regionalized Vaccine Manufacturing Collaborative Side Event.

Key Points: 
  • Jaeyong Ahn, CEO of SK bioscience, presents the 'Glocalization' project to secure the global vaccine accessibility, claiming the importance of international cooperation to establish a regional-based vaccine hub at the Regionalized Vaccine Manufacturing Collaborative Side Event.
  • The RVMC is a global initiative launched at the World Economic Forum (WEF) in May 2022 to address inequality in vaccine distribution between few rich countries and low- and middle-income countries during the COVID-19 pandemic.
  • SK bioscience came up with a regional-based vaccine hub as a business model during the COVID-19 pandemic when inequality in COVID-19 vaccine distribution was exposed.
  • Currently, SK bioscience is preparing to establish the regional vaccine hubs in the Middle East, Africa, Southeast Asia, and Latin America.

Axena Health Begins First-of-Its-Kind Global Study of Female Incontinence

Retrieved on: 
Wednesday, May 17, 2023
Health, Medical Devices, Consumer, Women, General Health, Pharmaceutical, Biotechnology, Well, AXA, PFMT, FI, Cigna, Fecal incontinence, Mother, MD, Disease, Society, GAVI, Johnson, Urinary incontinence, Bill & Melinda Gates Foundation, The Green Journal, Health equity, Ageing, Hope, Innovation, Research, UNICEF, Government, MS, Local government in Nepal, Organization, DPT, Equality, RCT, Johns Hopkins University Center for Communication Programs, BOSCH, Incontinence, Global Health, Ministry, Ministry of Health (Singapore), World Health Organization, United, MPH, Fistula, Family, UI, Woman, Leva, Female, Pharmaceutical industry, Nursing, Gynaecology, MBBS, Obstetrics

Axena Health, Inc. (Axena Health), a women’s health medical device company focused on scalable treatments for female pelvic health, announced today a large-scale study that will investigate the burdens of incontinence on women in low- and middle-income countries to support equitable access to treatment.

Key Points: 
  • Axena Health, Inc. (Axena Health), a women’s health medical device company focused on scalable treatments for female pelvic health, announced today a large-scale study that will investigate the burdens of incontinence on women in low- and middle-income countries to support equitable access to treatment.
  • “Urinary incontinence is a global health problem,” said Jessica McKinney, DScPT, MS, co-author of ‘ Implementing Physical Rehabilitation Services into Comprehensive Fistula and Maternity Care: A Training Guide for Health Workers ’, and Axena Health’s VP of Clinical Affairs and Global Health.
  • The burden of incontinence is gendered, and the costs borne by individuals and societies is multifactorial,” said Laura Keyser, DPT, MPH, co-author of the aforementioned Training Guide, and Director of Clinical Strategy and Global Health at Axena Health.
  • “Female incontinence is a significant unmet health need for millions of women worldwide, and we believe we’re uniquely able to help,” said Eileen Maus, CEO of Axena Health.

Global Hepatitis B Virus (HBV) Vaccine Market Report 2023: A $3.04 Billion Market by 2027 from $2.23 Billion in 2021 - Favorable Government Initiatives and Policies Bodes Well for the HBV Landscape - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 31, 2023
Infectious Diseases, Pharmaceutical, Health, Cirrhosis, Vaccination, Bill & Melinda Gates Foundation, Vaccine, Hepatitis B vaccine, World Health Organization's response to the COVID-19 pandemic, Hospital, Mono, Merck & Co., Urbanization, Hepatitis, Patient, ROW, HBV, Public Health England, GAVI, Research, Liver cancer, GSK plc, Food, Global Alliance, Risk, WHO, Antibody, Growth, Infection, Drug design, Hepatitis B virus, Prevalence, US Foods, COVID-19, Composition, Hepatitis B, Pharmaceutical industry, Hepatitis A and B vaccine, EU, Immunization

The global hepatitis B virus (HBV) vaccine market was valued at US$2.23 billion in 2021, and is predicted to grow to US$3.04 billion in 2027.

Key Points: 
  • The global hepatitis B virus (HBV) vaccine market was valued at US$2.23 billion in 2021, and is predicted to grow to US$3.04 billion in 2027.
  • Following the approval of the first hepatitis B vaccine in 1981, there has been significant progress in hepatitis B vaccines.
  • In the report, the global hepatitis B virus (HBV) vaccine market is divided into five regions: The US, China, Europen Union, Japan, and ROW.
  • The hepatitis B vaccine market in the US is a significant market, with a high demand for the vaccine due to the ongoing threat of hepatitis B virus (HBV) infection.

G20 ambitious on plan to roll out pandemic fund this year

Retrieved on: 
Friday, June 24, 2022
ACT, USD, Lists of countries and territories, Global, World Bank, Pandemic, COVID-19, GAVI, Bill & Melinda Gates Foundation, Union, Access to COVID-19 Tools Accelerator, Finance, The Global Fund to Fight AIDS, Tuberculosis and Malaria, PPR, World, Central bank, Therapy, FIF, Vaccine, CEPI, Research, Nature, Minister, G20, WHO, Animal, Health insurance

"I am pleased to announce a commitment of over USD 1.1 billion has been secured for the Financial Intermediary Fund for pandemic PPR."

Key Points: 
  • "I am pleased to announce a commitment of over USD 1.1 billion has been secured for the Financial Intermediary Fund for pandemic PPR."
  • G20 member states also highlighted that the fund would be inclusive in nature and allow access middle to low income countries to utilize it.
  • "This platform should be built on the experience of the ACT Accelerator, the Pandemic Influenza Framework and other mechanisms.
  • This is an important focus of the G20 health track under Minister Budi's leadership," he said.

G20 ambitious on plan to roll out pandemic fund this year

Retrieved on: 
Friday, June 24, 2022
ACT, USD, Lists of countries and territories, Global, World Bank, Pandemic, COVID-19, GAVI, Bill & Melinda Gates Foundation, Union, Access to COVID-19 Tools Accelerator, Finance, The Global Fund to Fight AIDS, Tuberculosis and Malaria, PPR, World, Central bank, Therapy, FIF, Vaccine, CEPI, Research, Nature, Minister, Multimedia, G20, WHO, Animal, Health insurance

"I am pleased to announce a commitment of over USD 1.1 billion has been secured for the Financial Intermediary Fund for pandemic PPR."

Key Points: 
  • "I am pleased to announce a commitment of over USD 1.1 billion has been secured for the Financial Intermediary Fund for pandemic PPR."
  • G20 member states also highlighted that the fund would be inclusive in nature and allow access middle to low income countries to utilize it.
  • Indonesian Health Minister Budi empasized that the G20 JFHTF has made progress in discussing further the idea of FIF establishment that was first introduced during 2021 Italian G20 presidency.
  • "This platform should be built on the experience of the ACT Accelerator, the Pandemic Influenza Framework and other mechanisms.

G20 committed to financing better pandemic response

Retrieved on: 
Wednesday, June 22, 2022
ANTARA, Trust law, FIF, GAVI, Mark R. Dybul, Therapy, COVID-19, Finance, Union, World, Bank, Global health, Vaccine, WHO, Human, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Lists of countries and territories, Epidemic, Coalition, Global Alliance, World Bank, CEPI, Health, World Health Organization, Pandemic, Wellcome Trust, G20, Coalition for Epidemic Preparedness Innovations, Pharmaceutical industry, Coal, Immunization

"The world is definitely watching us - how the G20 is going to respond with delivering concrete action in pandemic preparedness and response.

Key Points: 
  • "The world is definitely watching us - how the G20 is going to respond with delivering concrete action in pandemic preparedness and response.
  • "Only then, we can be effective in preparing to tackle the next global pandemic together," Mulyani stated.
  • The establishment of FIF is still in the ongoing discussion that will be continued at the next G20 meetings, hosted this year by Indonesia.
  • However, as the G20 President, Indonesia will continue to gather as much as possible support from more countries as well as an international organization even philanthropists, in order for them to be able to contribute to the financing side of pandemic preparedness and response.